NVAX
NASD Novavax, Inc.$11.75 ↓ -1.07 (-8.35%) Trading Down from the previous close of $12.82, $1.09 below the day’s high of $12.84
- YTD change
- +74.85%
- vs 20-day SMA
- +3.79%
- vs 200-day SMA
- +28.66%
Price ranges
Price & Performance
+4.18 (+48.38%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 96.5% away from all-time highs of $331.68
- NVAX is up 75% since the beginning of the year
- NVAX is up 39% over the past 12 months
- NVAX is up 18% over the past 1 month
- 28% of all NVAX investors are betting against NVAX
NVAX reads neutral: price sits above both the 20- and 200-day averages, the 12-month move is +51.2%.
- Previous minute
- -$0.03
- Last hour
- -$1.06
- Last 5 days
- +6.72%
- vs 8-day SMA
- -3.33%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.